PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES
DEAD

Serial Number

77741348

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

NADINE P. FLYNN

Filing Date

May 20, 2009

Add to watchlist:

No watchlists yet
View on USPTO

PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES Trademark

Serial Number: 77741348

PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on May 20, 2009. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,814 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Trademark Details

Filing Date

May 20, 2009

Registration Date

Not Registered

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 17, 2010 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 17, 2010 ABN2
NON-FINAL ACTION MAILED
Aug 18, 2009 CNRT
NON-FINAL ACTION WRITTEN
Aug 18, 2009 CNRT
ASSIGNED TO EXAMINER
Aug 10, 2009 DOCK
NOTICE OF PSEUDO MARK MAILED
May 27, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2009 NWOS
NEW APPLICATION ENTERED
May 23, 2009 NWAP